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The nasal vestibule is a major site of resistance to airflow in healthy subjects. A high nasal resistance may increase 
snoring. Activation of the alae nasi and alar retraction reduce resistance to airflow and improve ventilation. The 
Breathe Right@ (BR) device has been proposed to reduce or eliminate snoring by improving nasal breathing. We 
assessed the efficacy of BR on sleep quality and snoring during 2 full-night polysomnographies, the first without and 
the second with BR. Ten non-apnoeic snorers were studied. Snoring was present during 22-98% of total sleep time 
during the control night. Ear-nose-throat examination disclosed a nasal valve anomaly in five subjects, objectivated 
by anterior and posterior rhinomanometry. Quality of sleep and snoring were not influenced by BR, even when 
different sleep stages were analysed separately. No difference in snoring index was found between snorers with or 
without nasal valve anomaly. We conclude that BR is ineffective in relieving snoring in non-apnoeic snorers. 
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Introduction 
The Atlanta Olympic Games have created the notion that 
nasal breathing (and hence sports performance) can be 
facilitated by a nasal dilator. The Breathe Right@ (BR) is a 
simple device, in fact as simple as an adhesive tape, and is 
commonly used by athletes to improve nasal breathing 
during exercise. 
Everyone comes to the world with natural nasal dilators. 
Dilator naris muscles increase the cross-sectional area of 
the nostrils in physiological and physiopathological circum- 
stances. The nasal valve presents, with the glottis, the 
smallest cross-sectional area of the upper airways (1). 
Dilator naris muscles increase cross-sectional area of nasal 
valve during both tidal breathing and exercise (2). Phasic 
activity of dilator naris muscles is a common sign of 
dyspnoea, especially in children, i.e. nasal flaring. 
Recently, advertizing proposed the use of the BR to 
relieve snoring in habitual snorers (3). A lot of ‘simple’ 
remedies have been proposed to cure snoring, with limited, 
unknown or undocumented results (4-6). In the present 
study we verified the usefulness of BR in habitual non- 
apnoeic snorers. 
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Methods 
Breathe Right@ (CNS, Chanhassen, MN 55317, U.S.A.) is 
a non-invasive external nasal dilator. This adhesive elastic 
band is stuck at the anterior aspect of the nose. Its lateral 
sides dilate the nares by pulling apart alae nasi. 
Ten subjects (one female, mean f SD body mass index 
(BMI) 30.04 & 644 kg m ~ 2 and age 48 * 12.1 years) were 
recruited among a population of patients referred for 
snoring with or without day-time somnolence. A full- 
night diagnostic polysomnography was performed in each 
subject according to standard criteria as previously 
described (7). A microphone was glued on the patients’ 
neck. Snoring was designated on the basis of the character- 
istic microphone trace during sleep. Snoring index was 
defined as the number of 30-s sleep epochs with at least one 
snore over total number of sleep epochs, x 100. The 
desaturation index was the number of 24% desaturations 
per hour of sleep, related to abrupt reductions or 
cessation of oronasal flow signal, and was taken as the 
apnoea-hypopnoea index. 
An ear-nose-throat examination was done in each sub- 
ject and included anterior rhinoscopy, endonasal flexible 
endoscopy and both anterior and posterior semiquantita- 
tive rhinomanometry. Nasal valve anomaly was found in 
five subjects. 
A trial of BR was offered exclusively to non-apnoeic 
snoring patients. Snoring was present during 22-9874 of 
total sleep time. The patients were admitted overnight to 
undergo a second polysomnography with BR. 
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TABLE 1. Sleep and breathing data 
Mean SaO, (%) 95 i 2.3 
Min SaO, (%) 79 f 12.8 
SI 55.6 i: 27.9 
DI 15.1 + 14.4 
MA1 13.2 + 7.1 
TST (min) 365 f 91 
Stage 1 (%) 13.5 Zt 5.7 
Stage 2 (%) 50.2 f 13.7 
Stage 3 (%) 6.1 & 4.7 
Stage 4 (%) 7.9 i 5.1 
REM (%) 22.4 f 4.8 
95 f 2.1 ns. 
81 f 5.9 n.s. 
56.9 & 28.1 ns. 
16.9 f 8.2 ns. 
1.59 f 9.3 ns. 
393 f 58 n.s. 
17.1 & 6 ns. 
52.4 f 7.4 n.s. 
5.5 f 4.7 ns. 
6.7 f 7.4 n.s. 
18.2 f 6.4 n.s. 
Night 1, Control night; night 2, Breathe Right@’ trial night; 
min SaO,, minimal oxygen saturation; SI, snoring index 
(see text); DI, desaturation index (number of desaturations 
>4% h - i of sleep); MAI, movement arousal index, i.e. 
reappearance of an a-rhythm in the EEG during a sleep 
epoch, accompanied by an increase in EMG activity >2 s; 
TST, total sleep time; REM, rapid eye movement. 
n.s., Statistically non-significant. Values shown are 
mean f SD. 
TABLE 2. Snoring index during different sleep stages 
Stage 1 52.7 & 26.1 53.2 f 33.1 ns. 
Stage 1 64.4 f 29.0 64.6 f 30.6 n.s. 
Stage 1 58.8 f 36.2 50.0 f 39.9 n.s. 
Stage 1 46.3 f 43.9 39.9 zt 43.7 n.s. 
REM 35.8 f 31.2 39.4 =t 38.8 n.s. 
Night 1, Control night; night 2, Breathe Right@ trial 
night; REM, rapid eye movement. ns., statistically non- 
significant. Values shown are mean * SD. 
Polysomnographic data were compared using a Student’s 
t-test for paired samples. A P value ~0.5 was considered as 
significant. 
Results 
The interval between control and BR polysomnographies 
was 69 & 53 days (mean f SD). The BMI of the subjects did 
not change significantly between the two recordings. 
Table 1 presents mean f SD polysomnographic par- 
ameters during the control night and the night with BR. 
For the group as a whole, no statistical difference was 
found between any of the polysomnographic variables. 
Table 2 shows average snoring index values during different 
sleep stages. Again, no statistically significant difference 
was found between the 2 nights. Apnoea episodes were 
observed in four out of the 10 subjects during both nights 1 
and 2. 
Apnoea index (number of cessation of oronasal flow 
210s h-’ of sleep) was 2.3 & 4.08 (mean f SD) during the 
diagnostic night and 3.5 & 4.88 during the treatment night. 
Again, these results were not statistically different. 
When the data of the five patients with nasal valve 
anomaly were treated separately, the difference between 
variables from the two polysomnographies remained non- 
significant. Only one subject showed a reduction in the 
snoring index by more than 50%, from 26% to 6%. This 
patient had a nasal valve anomaly. Average BMI of the 
patients with nasal valve pathology was significantly lower 
than that of the five remaining subjects (254 ZIZ 1.8 and 
34.7 It 6.0 kg m - 2, respectively, P~0.05 by independent 
Student’s t-test). 
Discussion 
We have shown that the BR has no effect on snoring and 
other sleep parameters in non-apnoeic snoring patients with 
or without nasal valve anomaly. 
Snoring, a respiratory sound occurring during sleep, may 
be a cause of divorce (8). Many patients come to sleep 
laboratories to obtain help to relieve the snoring sound, 
rather than because they are aware of health hazards to 
which it has been associated (9,lO). In any case, the 
physician has to propose the best treatment with the least 
side-effects. The practitioners must be conscious that vari- 
ous treatments exist but few are efficient or have been 
studied objectively. 
The BR increases anterior nasal cross-sectional area and 
therefore might decrease nasal airflow resistance. Previous 
studies have shown that nasal route is an important key in 
the control of breathing, especially during sleep. Nasal 
obstruction is accompanied by increased sleep-disordered 
breathing (11,12). However, Miljeteig et al. (13) did not find 
differences in apnoea or snoring indices among patients 
with normal or increased nasal resistance. The hypothesis 
that decreased nasal resistance may relieve snoring has 
previously been exploited by another nasal dilator: the 
Nozovent=. As in our study, this device failed to de- 
crease snoring index in polysomnographic studies (14,15). 
Hoffstein et al. found that Nozovent@ reduced significantly 
snoring parameters only during slow wave sleep (15). 
However, we did not find similar results with the BR when 
snoring was analysed during different sleep stages (Table 2). 
The efficacy of BR on relieving nasal obstruction is not 
yet established. Nasal valve represents only a part of nasal 
resistance, which could be modified by a nasal dilator. In a 
recent abstract, Nepomuceno et al. (16) have studied the 
effect of BR on total inspiratory resistance (TIR) in seven 
normal subjects. These authors showed that TIR decreased 
in only four subjects when BR was in place. Resistance 
increased in two subjects and remained constant in one. We 
are not aware of a study on the effect of BR on nasal 
resistance in patients with nasal obstruction. 
Interestingly, patients with nasal valve anomaly, were 
significantly thinner than patients without. The fact that 
BR was as useless in the former as in the latter subjects 
suggests that an abnormal nasal valve is a marker of more 
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general anatomical characteristics (17) responsible for 6. 
snoring rather than its essential cause. 7. 
Lack of difference between snoring index and other sleep 
parameters between the two polysomnographies reminds us 
that a ‘good and simple treatment’ must also be tested 
objectively. 8. 
This study was not randomized. Indeed, a diagnostic 
polysomnography was performed first, and the ‘therapeu- 
tic’ night followed. To perform a randomized study would 
been required a 3rd night without the BR; this was techni- 
cally difficult and practically impossible. However, rand- 
omization is essential when a significant effect is found due 
to an intervention, and one has to make sure that this effect 
is a real one and not a placebo one. Our study shows 
negative findings and randomization is therefore not 
essential. 
9. 
10. 
In conclusion the Breathe Right@ does not appear useful 
to relieve snoring in non-apnoeic snorers. 
11. 
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